Related Experiment Video
Updated: May 2, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes
C N Castro1, A E Barcala Tabarrozzi, J Winnewisser
1Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA), CONICET - Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
Abstract:
Type 1 diabetes (T1DM) is a T cell-mediated autoimmune disease that selectively destroys pancreatic β cells. The only possible cure for T1DM is to control autoimmunity against β cell-specific antigens. We explored whether the natural compound curcumin, with anti-oxidant and anti-inflammatory activities, might down-regulate the T cell response that destroys pancreatic β cells to improve disease outcome in autoimmune diabetes. We employed two accelerated autoimmune diabetes models: (i) cyclophosphamide (CYP) administration to non-obese diabetic (NOD) mice and (ii) adoptive transfer of diabetogenic splenocytes into NODscid mice. Curcumin treatment led to significant delay of disease onset, and in some instances prevented autoimmune diabetes by inhibiting pancreatic leucocyte infiltration and preserving insulin-expressing cells. To investigate the mechanisms of protection we studied the effect of curcumin on key immune cell populations involved in the pathogenesis of the disease. Curcumin modulates the T lymphocyte response impairing proliferation and interferon (IFN)-γ production through modulation of T-box expressed in T cells (T-bet), a key transcription factor for proinflammatory T helper type 1 (Th1) lymphocyte differentiation, both at the transcriptional and translational levels. Also, curcumin reduces nuclear factor (NF)-κB activation in T cell receptor (TCR)-stimulated NOD lymphocytes. In addition, curcumin impairs the T cell stimulatory function of dendritic cells with reduced secretion of proinflammatory cytokines and nitric oxide (NO) and low surface expression of co-stimulatory molecules, leading to an overall diminished antigen-presenting cell activity. These in-vitro effects correlated with ex-vivo analysis of cells obtained from curcumin-treated mice during the course of autoimmune diabetes. These findings reveal an effective therapeutic effect of curcumin in autoimmune diabetes by its actions on key immune cells responsible for β cell death.
Insights
Curcumin, a natural compound, may treat type 1 diabetes by reducing harmful T cell responses and inflammation, protecting insulin-producing cells. This research explores curcumin
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- Type 1 diabetes (T1DM) is an autoimmune disease targeting pancreatic beta cells.
- Current treatments focus on managing hyperglycemia, not curing the underlying autoimmunity.
Purpose of the Study:
- To investigate curcumin's potential to modulate T cell responses and prevent autoimmune diabetes.
- To elucidate the mechanisms by which curcumin exerts its protective effects.
Main Methods:
- Utilized two accelerated autoimmune diabetes models in non-obese diabetic (NOD) mice.
- Administered cyclophosphamide (CYP) and performed adoptive transfer of diabetogenic splenocytes.
- Assessed the impact of curcumin on T cell proliferation, cytokine production (IFN-γ), transcription factors (T-bet), signaling pathways (NF-κB), and dendritic cell function.
Main Results:
- Curcumin significantly delayed or prevented autoimmune diabetes onset.
- Curcumin inhibited pancreatic leukocyte infiltration and preserved insulin-expressing cells.
- Curcumin modulated T lymphocyte responses, reducing proliferation and IFN-γ production via T-bet regulation.
- Curcumin decreased NF-κB activation and impaired dendritic cell stimulatory function.
Conclusions:
- Curcumin demonstrates therapeutic potential for autoimmune diabetes.
- Curcumin acts on key immune cells, including T lymphocytes and dendritic cells, to reduce autoimmune attack on beta cells.
- These findings support curcumin as a potential agent for managing T1DM by targeting its autoimmune basis.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

